Plasma adropin level in patients with pseudoexfoliation

Basit Öğe Kaydı
dc.contributor.authorOğurel, Tevfik
dc.contributor.authorOğurel, Reyhan
dc.contributor.authorTopuz, Mustafa
dc.contributor.authorÖrnek, Nurgül
dc.contributor.authorÖrnek, Kemal
dc.date.accessioned2020-06-25T18:16:10Z
dc.date.available2020-06-25T18:16:10Z
dc.date.issued2016
dc.departmentKırıkkale Üniversitesi, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü
dc.descriptionOrnek, Nurgul/0000-0003-3068-1831;
dc.description.abstractThe aim of this study was to evaluate plasma adropin levels in patients with pseudoexfoliation (PEX). This retrospective case-control study included 35 patients with PEX and 35 individuals without PEX who served as controls. Plasma adropin levels with triglycerides, total cholesterol, low-density lipoprotein (LDL), high-density lipoprotein (HDL), and haemoglobin A1c (HGBA1C) concentrations were measured in both groups. The mean serum adropin levels were 3.24 +/- 0.95 ng/mL (range, 1.90-7.88 ng/mL) in patients with PEX syndrome and 5.78 +/- 2.85 ng/mL (range, 2.08-5.41 ng/mL) in PEX glaucoma patients. There was no statistically significant difference in mean adropin levels between PEX syndrome and PEX glaucoma patients. However, similar adropin levels were found in the PEX glaucoma patients and the control group (P > 0.05). The mean serum adropin levels were 3.34 +/- 0.89 ng/mL (range, 1.90-5.39 ng/mL) in the PEX group and 5.78 +/- 2.85 ng/mL (range, 3.08-11.06 ng/mL) in the control group. The mean serum adropin level of the PEX group was significantly lower than that of the control group (P < 0.001). There were no significant differences between the two groups in terms of serum glucose, total cholesterol, LDL, HDL, HGBA1C, triglycerides levels, or body mass index (all P > 0.05). Adropin level is lower in patients with PEX.en_US
dc.identifier.citationclosedAccessen_US
dc.identifier.doi10.1007/s10792-016-0185-8
dc.identifier.endpage742en_US
dc.identifier.issn0165-5701
dc.identifier.issn1573-2630
dc.identifier.issue5en_US
dc.identifier.pmid26861473
dc.identifier.scopus2-s2.0-84957654978
dc.identifier.scopusqualityQ2
dc.identifier.startpage737en_US
dc.identifier.urihttps://doi.org/10.1007/s10792-016-0185-8
dc.identifier.urihttps://hdl.handle.net/20.500.12587/6439
dc.identifier.volume36en_US
dc.identifier.wosWOS:000383601800020
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherSpringeren_US
dc.relation.ispartofInternational Ophthalmology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAdropinen_US
dc.subjectPseudoexfoliation syndromeen_US
dc.subjectGlaucomaen_US
dc.titlePlasma adropin level in patients with pseudoexfoliationen_US
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
Oğurel2016_Article_PlasmaAdropinLevelInPatientsWi.pdf
Boyut:
348.41 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
İndir

Koleksiyon

WOS İndeksli Yayınlar Koleksiyonu
Makale Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu